4DMedical (ASX:4DX) announced a three-year contract with UC San Diego (UCSD) Health, ranked among the top 10 U.S. hospitals for respiratory care. This agreement brings 4DMedical’s innovative lung imaging technology to clinical use at one of the nation’s leading medical centers.
4DMedical’s XV Technology transforms the way respiratory function is assessed. Traditional imaging techniques, such as X-rays and CT scans, provide static views of lung structures but fail to capture the dynamic way the lungs work. XV Technology changes this by using motion analytics to monitor airflow in real time, allowing doctors to detect underperforming areas of the lungs earlier and with greater precision.
The technology works according to a Software as a Service (SaaS) model.
This contract will initially see UCSD Health adopt 4DMedical’s CT-based imaging tools, with potential expansion to its full portfolio, including the XV scanner. The XV scanner is a dedicated lung imaging device that captures four-dimensional views of lung function during normal breathing. Unlike standard imaging methods, it is noninvasive, requires no contrast agents, and uses less radiation than a chest x-ray. The scanner is specifically designed to work with 4DMedical’s XV Lung Ventilation Analysis (XV LVAS) software.
“This partnership with UCSD Health highlights the growing recognition of 4DMedical’s innovative technology in transforming respiratory care,” said Managing Director and CEO Andreas Fouras. “Their status as one of the top respiratory hospitals in the country will undoubtedly enhance our commercialization efforts within the broader U.S. healthcare system.”